A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

NCT00000658 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

NIH

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
HIV Infections

Interventions

DRUG: Bleomycin sulfate
DRUG: Vincristine sulfate
DRUG: Doxorubicin hydrochloride
DRUG: Cyclophosphamide
DRUG: Allopurinol
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Leucovorin calcium
DRUG: Sargramostim
DRUG: Dexamethasone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]